Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NASDAQ:ALNY
Tag: NASDAQ:ALNY
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has coverage initiated with a Neutral rating
ME Staff
-
January 23, 2019
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) Files An 8-K Entry into a Material...
ME Staff 8-k
-
January 15, 2019
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) had its Buy rating reiterated by Cantor...
ME Staff
-
December 7, 2018
0
Alnylam Pharmaceuticals (NASDAQ:ALNY) reported earnings of ($2.43) per share missing Walls...
ME Staff
-
November 7, 2018
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) reported earnings of ($2.43) per share missing...
ME Staff
-
November 7, 2018
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) had its Buy rating reiterated by BMO...
ME Staff
-
October 18, 2018
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) price target lowered to $124.00 by BMO...
ME Staff
-
October 16, 2018
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has coverage initiated with a Overweight ➝...
ME Staff
-
October 1, 2018
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) has coverage initiated with a Overweight rating...
ME Staff
-
October 1, 2018
0
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) price target lowered to $87.00 by Morgan...
ME Staff
-
September 28, 2018
0
1
2
3
...
7
Page 2 of 7
